Calquence 100 MG Oral Capsule
- RxCUI
- 1986819
- RxNorm name
- Calquence 100 MG Oral Capsule
- Display name
- Calquence 100 MG Oral Capsule
- Full name
- Calquence 100 MG Oral Capsule
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CALQUENCE | ACALABRUTINIB | AstraZeneca Pharmaceuticals LP | dd4835ef-e1bc-4997-a399-1ffa2556fbfe | 2026-02-19 | Warnings, Adverse reactions | 1986819 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| dd4835ef-e1bc-4997-a399-1ffa2556fbfe | Calquence 100 MG Oral Capsule | PSN | 27 | These highlights do not include all the information needed to use CALQUENCE safely and effectively. See full prescribing information for CALQUENCE. CALQUENCE ® (acalabrutinib) capsules, for oral use Initial U.S. Approval: 2017 | 20260219 |
| dd4835ef-e1bc-4997-a399-1ffa2556fbfe | Calquence 100 MG Oral Capsule | SY | 27 | These highlights do not include all the information needed to use CALQUENCE safely and effectively. See full prescribing information for CALQUENCE. CALQUENCE ® (acalabrutinib) capsules, for oral use Initial U.S. Approval: 2017 | 20260219 |
| dd4835ef-e1bc-4997-a399-1ffa2556fbfe | acalabrutinib 100 MG Oral Capsule [Calquence] | SBD | 27 | These highlights do not include all the information needed to use CALQUENCE safely and effectively. See full prescribing information for CALQUENCE. CALQUENCE ® (acalabrutinib) capsules, for oral use Initial U.S. Approval: 2017 | 20260219 |